Global Cell Culture Market Report 2022: Growing Awareness About the Benefits of Cell-Based Vaccines and Launch of Advanced Cell Culture Products to Drive Sector

DUBLIN, Nov. 28, 2022 /PRNewswire/ -- The "Global Cell Culture Market by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) - Forecast to 2026" report has been added to  ResearchAndMarkets.com's offering.

The global cell culture market is projected to USD 41.3 billion by 2026 from USD 22.8 billion in 2021, at a CAGR of 12.6 % between 2021 and 2026. The growth of this market is majorly driven by the growing awareness about the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, the launch of advanced cell culture products, and the growing focus on personalized medicine. On the other hand, the high cost of cell biology research is restraining the growth of this market.

The consumables segment accounted for the highest growth rate in the cell culture market, by product, during the forecast period

In 2020, the consumables segment accounted for the highest growth rate. The cell culture consumables are segmented into sera, media, reagents; vessels; and accessories. The sera, media and reagents segment is expected to account for the largest share of the cell culture consumables markets. The large share of this segment is attributed to the repeated purchase and requirement in bulk quantities of sera, media, and reagents for various cell culture applications. Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Corning Incorporated (US), Eppendorf AG (Germany), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Getinge AB (Sweden), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), HiMedia Laboratories (India) are some of the major players operating in the cell culture market.

Asia Pacific: The fastest-growing region in the cell culture market

The cell culture market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific market is estimated to register the highest CAGR of 14.0% during the forecast period. Government initiatives for research on stem cell therapy, growing geriatric population, the rising prominence of regenerative medicine research, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical & biopharmaceutical sectors in South Korea are the major factors contributing to the growth of the cell culture market in the Asia Pacific.

Market Dynamics

Drivers

• Growing Awareness About the Benefits of Cell-Based Vaccines
• Increasing Demand for Monoclonal Antibodies
• Funding for Cell-Based Research
• Growing Preference for Single-Use Technologies
• Launch of Advanced Cell Culture Products
• Growing Focus on Personalized Medicine

Restraints

• High Cost of Cell Biology Research
• Limitations in the Production of High-Density Cell Cultures

Opportunities

• Growing Demand for 3D Cell Culture
• Growing Risk of Pandemics and Communicable Diseases
• Emerging Economies

Challenges

• Plastic Waste Disposal

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Corning Incorporated (US)
• Eppendorf AG (Germany)
• FUJIFILM Irvine Scientific, Inc. (Japan)
• Lonza Group AG (Switzerland)
• Sartorius AG (Germany)
• Agilent Technologies, Inc. (US)
• Getinge AB (Sweden)
• Becton, Dickinson and Company (US)
• Miltenyi Biotec (Germany)
• HiMedia Laboratories (India)
• STEMCELL Technologies Inc. (Canada)
• Solida Biotech GmbH (Germany)
• Caisson Laboratories Inc. (US)
• PromoCell GmbH (Germany)
• InvivoGen (US)
• Pan-Biotech GmbH (Germany)
• Cellexus (UK)
• Meissner Filtration Products Inc. (US)
• Adolf Kuhner AG (Switzerland)
• SeraCare Life Sciences Inc. (US)
• ANGUS Chemical Company (US)
• Biospherix Ltd. (US)

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Cell Culture Market, by Product

7 Cell Culture Market, by Application

8 Cell Culture Market, by End-user

9 Cell Culture Market, by Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/9z46ly

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-cell-culture-market-report-2022-growing-awareness-about-the-benefits-of-cell-based-vaccines-and-launch-of-advanced-cell-culture-products-to-drive-sector-301687753.html

SOURCE Research and Markets